Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker 2 hours ago


Jean-Paul Clozel, the chief executive officer and co-founder of Actelion Ltd., has become a billionaire with Johnson & Johnson's interest in the Swiss drug company. website , such as pulmonary arterial hypertension, characterized by abnormally high blood pressure in the arteries between the heart and lungs.



from Biotech News